Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription 30.03.2026 2 AIDS 1 Dig Dis Sci 1 Gastroenterol Hepatol 1 J Hepatol 1 J Viral Hepat 1 J Virol 1 JAMA 3 PLoS One 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. CHALOUNI M, Torgersen J, Rentsch CT, Van Santen DK, et al
   Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004499.
   PubMed         Abstract available
   
   
2. MCFARLANE WJ, Brogly SB, Flemming JA, Martinez-Cajas J, et al
   HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.
   AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004501.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

3. ALMUSABEH H, Kovach Z, Lloyd L, Alzaher MZ, et al
   Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database.
   Dig Dis Sci. 2026 Mar 25. doi: 10.1007/s10620-026-09854.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

4. MESONERO B, Zanabili J, Granda E, Rodriguez M, et al
   Functional cure of chronic hepatitis B: the friendly face of allogenic hematopoietic stem cell transplantation.
   Gastroenterol Hepatol. 2026 Mar 23:502721. doi: 10.1016/j.gastrohep.2026.502721.
   PubMed        
   
   

   
   J Hepatol

5. XU Y, Weltzsch JP, Kilian C, Steglich B, et al
   Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis.
   J Hepatol. 2026 Mar 19:S0168-8278(26)00120-0. doi: 10.1016/j.jhep.2026.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

6. HILL KC, Brinkley S, Latimer M, Tichnell P, et al
   Utilizing Telemedicine to Engage Rural Patients With Substance Use Disorders in Low Barrier Hepatitis C Treatment.
   J Viral Hepat. 2026;33:e70173.
   PubMed         Abstract available
   
   

   
   J Virol

7. XIA Y, Chen S, He Q, Cong C, et al
   HEV replication is promoted by blocking the NF-kappaB signaling pathway through inhibiting FLNa expression.
   J Virol. 2026;100:e0197725.
   PubMed         Abstract available
   
   

   
   JAMA

8. KISHORE S, Hayden M, Johnson M, Kesselheim AS, et al
   National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C.
   JAMA. 2026 Mar 25:e263328. doi: 10.1001/jama.2026.3328.
   PubMed        
   
   

   
   PLoS One

9. JENA M, Dehuri S, Cho SB
   SGA-DT: An adaptive fusion framework for missing data imputation and interpretable healthcare classification.
   PLoS One. 2026;21:e0343619.
   PubMed         Abstract available
   
   
10. HA VN, Cao LC, Dang TH, Huyen DT, et al
    Hepatitis E virus exposure and risk factors among ethnic minority populations in Northern Vietnam.
    PLoS One. 2026;21:e0345566.
    PubMed         Abstract available
    
    
11. BESTARI MB, Wijaya MP, Girawan D, Agustanti N, et al
    Unveiling the role of interleukin-13 in liver fibrosis of chronic hepatitis B patients: Development of a predictive model.
    PLoS One. 2026;21:e0344791.
    PubMed         Abstract available
    
    

    
    Vaccine

12. HUANG A, Li J, Tang L, Xu X, et al
    Cost-effectiveness of hepatitis A vaccination for adults in China: A decision tree Markov model study.
    Vaccine. 2026;79:128509.
    PubMed         Abstract available
    
    

    
    Virology

13. BROWN HM, Meng XJ
    The evolution of in vitro culture systems for the study of hepatitis E virus infection.
    Virology. 2026;619:110886.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum